pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Mayo Clinic

updated 4mo ago

Mayo Clinic is a private American academic medical center focused on integrated healthcare, education, and research. It maintains three major campuses in Rochester, Minnesota; Jacksonville, Florida; and Phoenix/Scottsdale, Arizona.

community read0 votes

🐶 often sniffed alongside

top 8
  • tagOncology7 co-mentions · 6 sources
  • tagGlioblastoma4 co-mentions · 1 sources
  • tagEndocrinology & Metabolism4 co-mentions · 4 sources
  • tagImmunology3 co-mentions · 3 sources
  • tagPain2 co-mentions · 2 sources
  • tagHematology1 co-mentions · 1 sources
  • tagNephrology1 co-mentions · 1 sources
  • tagCardiology1 co-mentions · 1 sources
pipeline
1
marketed
0
phase 3
0
catalysts ytd
19
approvals ytd
0
recalls ytd
0

Pipeline(1)

pipeline depth1 products
Unknown: 1
1Unknown
drug
kava

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase2Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Canceractive not recruitingn=38
  • N/AHigh Flow Nasal Cannula Compared to Standard Oxygen for Endoscopic Ultrasoundactive not recruitingn=200
  • N/AAdverse Outcomes and Mortality in Liver Transplantrecruitingn=100
  • phase4Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Studyrecruitingn=1,335
  • N/AA Study of Virtual Reality and Linaclotide for IBS-Crecruitingn=65
  • phase4A Study of a Novel Precision Medicine Approach For Obesityactive not recruitingn=135
  • —Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patientsrecruitingn=750
  • N/APilot Evaluation of the StarGuide Next Generation SPECT/CT Systemenrolling by invitationn=100
🐶 Hiring Signal
No open roles indexed yet — view Mayo Clinic jobs →

News

  • Mayo Clinic teams with Thermo Fisher to form biomedical data group Precure
    The Mayo Clinic has partnered with Thermo Fisher Scientific to launch a new group focused on reaping large-scale data that could lead to the understanding and development of new treatments, devices…
    fiercebiotech · 19d ago
  • Capricor, Replimune illustrate why FDA must listen to rare disease specialists
    Last month’s FDA advisory committee meetings for therapies developed by Capricor Therapeutics and Replimune effectively illustrate the different outcomes for patients when the agency prioritizes sp…
    biospace · 1mo ago
  • Meet Aletta: The first FDA approved robotic blood draw device
    The FDA has approved Vitestro’s Aletta as the first standalone robotic device in the U.S. designed to draw blood without the need for hands-on human help.
    fiercebiotech · 1mo ago
  • Opinion: How to disrupt the health misinformation business model
    One way to fight medical misinformation: make it easier for people to understand when they are being manipulated, write Paul Martin Jensen and Avi Tuschman.
    stat · 1mo ago
  • Replimune’s twice-rejected melanoma drug prevails in FDA adcomm
    Following a pair of FDA rejections of its melanoma drug, Replimune’s fortunes flipped today after an advisory committee voted 10 to 3 in favor of the candidate’s effectiveness.
    fiercebiotech · 2mo ago
  • STAT+: The whistleblower, The Lab, and the fine print
    In this AI Prognosis news roundup: Mayo's AI whistleblower, Sutter Health's reply to lawsuit over Abridge scribe, and more.
    stat · 2mo ago
  • Kardigan extends biotech’s streak of big IPOs with $400M haul
    Including the heart drug developer’s offering, four biotechs in 2026 have raised at least $400 million in IPO proceeds — the most in a single year since 2021, according to BioPharma Dive data.
    biopharma_dive · 3mo ago
  • How AI helped treat a newborn’s ultra rare disease. ‘It was almost like a light switch.’
    The parents of Jorie Kraus told the audience at STAT's Breakthrough Summit West about how AI helped their daughter who was born with a rare disease.
    stat · 4mo ago
  • Opinion: Hospitals are silencing doctors online, and it’s fueling the health misinformation crisis
    Hospitals and health systems need to loosen the reins and let physicians combat social media misinformation, writes Adam Goodcoff.
    stat · 4mo ago
  • Opinion: STAT readers on MAHA activists, perimenopause, and diversity in medical school
    “Unfortunately, the resources don't exist to take every flat-earther to the International Space Station to change their mind,” a STAT reader writes.
    stat · 5mo ago
view all news mentions →
identifiers
source
globaldata
mentioned in
10news items
entity-linker matched

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?